Global CRISPR Knockout Cell Lines Market Research Report 2025

Publication ID:

PB503250430

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for CRISPR Knockout Cell Lines was valued at US$ 364 million in the year 2024 and is projected to reach a revised size of US$ 534 million by 2031, growing at a CAGR of 5.7% during the forecast period.
CRISPR knockout cell lines are genetically modified cells in which a specific gene has been knocked out using CRISPR/Cas9 gene editing technology. CRISPR/Cas9 is a powerful tool that allows for precise, targeted disruption of genes, making it ideal for generating knockout cell lines for studying gene function.
North American market for CRISPR Knockout Cell Lines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CRISPR Knockout Cell Lines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CRISPR Knockout Cell Lines in Basic Biological Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CRISPR Knockout Cell Lines include editxor, GenScript, EditCo, Applied Biological Materials Inc. (abm), Cyagen, Creative Biogene, BPS Bioscience, VectorBuilder, GeneCopoeia, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Knockout Cell Lines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Knockout Cell Lines.
The CRISPR Knockout Cell Lines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR Knockout Cell Lines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Knockout Cell Lines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
editxor
GenScript
EditCo
Applied Biological Materials Inc. (abm)
Cyagen
Creative Biogene
BPS Bioscience
VectorBuilder
GeneCopoeia
Segment by Type
Human CRISPR Knockout Cell Lines
Mouse CRISPR Knockout Cell Lines
Other
Segment by Application
Basic Biological Research
Disease Diagnosis and Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Knockout Cell Lines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Knockout Cell Lines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human CRISPR Knockout Cell Lines
1.2.3 Mouse CRISPR Knockout Cell Lines
1.2.4 Other
1.3 Market by Application
1.3.1 Global CRISPR Knockout Cell Lines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Basic Biological Research
1.3.3 Disease Diagnosis and Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Knockout Cell Lines Market Perspective (2020-2031)
2.2 Global CRISPR Knockout Cell Lines Growth Trends by Region
2.2.1 Global CRISPR Knockout Cell Lines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR Knockout Cell Lines Historic Market Size by Region (2020-2025)
2.2.3 CRISPR Knockout Cell Lines Forecasted Market Size by Region (2026-2031)
2.3 CRISPR Knockout Cell Lines Market Dynamics
2.3.1 CRISPR Knockout Cell Lines Industry Trends
2.3.2 CRISPR Knockout Cell Lines Market Drivers
2.3.3 CRISPR Knockout Cell Lines Market Challenges
2.3.4 CRISPR Knockout Cell Lines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Knockout Cell Lines Players by Revenue
3.1.1 Global Top CRISPR Knockout Cell Lines Players by Revenue (2020-2025)
3.1.2 Global CRISPR Knockout Cell Lines Revenue Market Share by Players (2020-2025)
3.2 Global Top CRISPR Knockout Cell Lines Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR Knockout Cell Lines Revenue
3.4 Global CRISPR Knockout Cell Lines Market Concentration Ratio
3.4.1 Global CRISPR Knockout Cell Lines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Knockout Cell Lines Revenue in 2024
3.5 Global Key Players of CRISPR Knockout Cell Lines Head office and Area Served
3.6 Global Key Players of CRISPR Knockout Cell Lines, Product and Application
3.7 Global Key Players of CRISPR Knockout Cell Lines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Knockout Cell Lines Breakdown Data by Type
4.1 Global CRISPR Knockout Cell Lines Historic Market Size by Type (2020-2025)
4.2 Global CRISPR Knockout Cell Lines Forecasted Market Size by Type (2026-2031)
5 CRISPR Knockout Cell Lines Breakdown Data by Application
5.1 Global CRISPR Knockout Cell Lines Historic Market Size by Application (2020-2025)
5.2 Global CRISPR Knockout Cell Lines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR Knockout Cell Lines Market Size (2020-2031)
6.2 North America CRISPR Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR Knockout Cell Lines Market Size by Country (2020-2025)
6.4 North America CRISPR Knockout Cell Lines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Knockout Cell Lines Market Size (2020-2031)
7.2 Europe CRISPR Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR Knockout Cell Lines Market Size by Country (2020-2025)
7.4 Europe CRISPR Knockout Cell Lines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Knockout Cell Lines Market Size (2020-2031)
8.2 Asia-Pacific CRISPR Knockout Cell Lines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR Knockout Cell Lines Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR Knockout Cell Lines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Knockout Cell Lines Market Size (2020-2031)
9.2 Latin America CRISPR Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR Knockout Cell Lines Market Size by Country (2020-2025)
9.4 Latin America CRISPR Knockout Cell Lines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Knockout Cell Lines Market Size (2020-2031)
10.2 Middle East & Africa CRISPR Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR Knockout Cell Lines Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR Knockout Cell Lines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 editxor
11.1.1 editxor Company Details
11.1.2 editxor Business Overview
11.1.3 editxor CRISPR Knockout Cell Lines Introduction
11.1.4 editxor Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.1.5 editxor Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript CRISPR Knockout Cell Lines Introduction
11.2.4 GenScript Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.2.5 GenScript Recent Development
11.3 EditCo
11.3.1 EditCo Company Details
11.3.2 EditCo Business Overview
11.3.3 EditCo CRISPR Knockout Cell Lines Introduction
11.3.4 EditCo Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.3.5 EditCo Recent Development
11.4 Applied Biological Materials Inc. (abm)
11.4.1 Applied Biological Materials Inc. (abm) Company Details
11.4.2 Applied Biological Materials Inc. (abm) Business Overview
11.4.3 Applied Biological Materials Inc. (abm) CRISPR Knockout Cell Lines Introduction
11.4.4 Applied Biological Materials Inc. (abm) Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.4.5 Applied Biological Materials Inc. (abm) Recent Development
11.5 Cyagen
11.5.1 Cyagen Company Details
11.5.2 Cyagen Business Overview
11.5.3 Cyagen CRISPR Knockout Cell Lines Introduction
11.5.4 Cyagen Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.5.5 Cyagen Recent Development
11.6 Creative Biogene
11.6.1 Creative Biogene Company Details
11.6.2 Creative Biogene Business Overview
11.6.3 Creative Biogene CRISPR Knockout Cell Lines Introduction
11.6.4 Creative Biogene Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.6.5 Creative Biogene Recent Development
11.7 BPS Bioscience
11.7.1 BPS Bioscience Company Details
11.7.2 BPS Bioscience Business Overview
11.7.3 BPS Bioscience CRISPR Knockout Cell Lines Introduction
11.7.4 BPS Bioscience Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.7.5 BPS Bioscience Recent Development
11.8 VectorBuilder
11.8.1 VectorBuilder Company Details
11.8.2 VectorBuilder Business Overview
11.8.3 VectorBuilder CRISPR Knockout Cell Lines Introduction
11.8.4 VectorBuilder Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.8.5 VectorBuilder Recent Development
11.9 GeneCopoeia
11.9.1 GeneCopoeia Company Details
11.9.2 GeneCopoeia Business Overview
11.9.3 GeneCopoeia CRISPR Knockout Cell Lines Introduction
11.9.4 GeneCopoeia Revenue in CRISPR Knockout Cell Lines Business (2020-2025)
11.9.5 GeneCopoeia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

editxor
GenScript
EditCo
Applied Biological Materials Inc. (abm)
Cyagen
Creative Biogene
BPS Bioscience
VectorBuilder
GeneCopoeia

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂